Seeing Is Believing
Currently out of the existing stock ratings of Allen Lutz, 18 are a BUY (40%), 24 are a HOLD (53.33%), 3 are a SELL (6.67%).
Analyst Allen Lutz, currently employed at BAML, carries an average stock price target met ratio of 44.88% that have a potential upside of 11.87% achieved within 75 days.
Allen Lutz’s has documented 89 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OMCL, Omnicell at 06-Jan-2025.
Analyst best performing recommendations are on DOCS (DOXIMITY).
The best stock recommendation documented was for DOCS (DOXIMITY) at 8/9/2023. The price target of $24 was fulfilled within 2 days with a profit of $1.3 (5.14%) receiving and performance score of 25.69.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$105
$-5.42 (-4.91%)
$92
1 months 22 days ago
(10-Dec-2024)
12/12 (100%)
$9.61 (10.07%)
232
Buy
$120
$9.58 (8.68%)
$105
1 months 30 days ago
(02-Dec-2024)
18/19 (94.74%)
$18.34 (18.04%)
194
Buy
$120
$9.58 (8.68%)
$100
2 months 19 days ago
(13-Nov-2024)
12/13 (92.31%)
$25.2 (26.58%)
107
Buy
$103
$-7.42 (-6.72%)
$88
4 months 28 days ago
(04-Sep-2024)
16/16 (100%)
$20.34 (24.61%)
183
Buy
$110
$-0.42 (-0.38%)
$107
7 months 12 days ago
(20-Jun-2024)
8/8 (100%)
$27.74 (33.72%)
580
Which stock is Allen Lutz is most bullish on?
Which stock is Allen Lutz is most reserved on?
What Year was the first public recommendation made by Allen Lutz?